Skip to main content
. 2016 Oct 27;6(1):45–53. doi: 10.1002/cam4.942

Figure 3.

Figure 3

Clinical outcomes of patients who received chemotherapy or chemotherapy plus CIT. Kaplan‐Meier survival analysis was used to compare three‐year DFS and OS rate between the chemo and the chemo/CIT group (DFS, 60.6% vs 74.7%, P = 0.036; OS, 64.9% vs 83%, P = 0.051).